EP-1469: Survey on the use of complementary and alternative medicine in a German radiooncology department  by Lettner, S. et al.
S680                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
Results: C1 = 109 patients (84 with breast cancer, 13 H&N, 
12 pelvis), C2= 104 (87B, 12H&N, 5P). In C1 27% used a cream 
and in C2 96% used a cream (p<0.001). In C2 88/104 complied 
with policy using the prescribed betamethasone.  
Compared to C1, for C2 the mean score was lower for itch 
(1.3 (0.8-1.8) v 2.8 (2.2-3.4) p<0.001) and discomfort (2.2 
(1.7-2.7) v 3.1 (2.6-3.7) (p=0.021), and when betamethasone 
was used (comparing the 88 from C2 with 125 from C1 or C2) 
the mean score was lower for itch (0.9 (0.5-1.4) v 2.9 (2.3-
3.4) p<0.001), discomfort (2.0 (1.4-2.5) v 3.2(2.6-3.7) 
p<0.003), and for pain (1.4 (0.9-1.9) v 2.2 (1.7-2.7) p=0.03).  
With the use of betamethasone, the frequency of a score of 
>5 was lower for redness (15% with v 34% without) p=0.002), 
itch (7% v 25%, p =0.001), discomfort (9% v 22%, p=0.015), but 
not for pain (9% v 14%, p=0.29). However, sleep disturbance 
was less common (7% v 21%, p=0.006), as was the use of 
analgesia (7% v 19%, p=0.015). 
 
Conclusion: The introduction of routine use of prophylactic 
betamethasone cream for patients with a high risk of 
radiation skin reaction resulted in a significant reduction in 
redness, itch, discomfort, sleep disturbance, and on use of 
analgesia 
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Purpose or Objective: The use of complementary and 
alternative medicine (CAM) continuously gains importance, 
even though objective data are mostly missing – also in 
radiation oncology. However, in previous trials methods such 
as acupuncture showed significant advantages compared to 
standard therapies. Hence, the aim of this study is to 
evaluate the most frequently used methods, their 
significance and potential effect during radiotherapy (RT), as 
well as the general acceptance amongst cancer patients. 
 
Material and Methods: A detailed questionnaire was 
developed consisting of 18 questions based on the categorical 
classification released by the National Centre for 
Complementary and Alternative Medicine (NCCAM). From 
January to September 2015, the survey was conducted with 
all patients undergoing RT at the department of Radiation 
Oncology, Technische Universität München (TUM), Klinikum 
rechts der Isar, Munich. Participation was voluntary and 
pseudonymous. 
 
Results: Of 571 patients, 289 answered the questionnaire 
(50.6%), with 44.6% females and 38.4% males participating in 
the study, and a mean age of 60 years. Of these, 66.1% 
(191/289) received RT only, 20.4% (59/289) had a combined 
radio-chemotherapy (RCT). Of all participants, 25.9% 
(75/289) used CAM parallel to RT. Before RT, a total of 40.8% 
(118/289) had already used complementary medicine. The 
current most frequently applied methods were vitamins, 
dietary supplements, homeopathy and physical therapy, 
whereas in the past before RT also acupuncture and 
osteopathy had been regularly used. The majority (72.6%, 
210/289) declined the use of any complementary treatment. 
Of these 210 patients, 73.3% (154/210) stated that CAM 
treatment was not offered to them. Only 20.4% (59/289) of 
all participants had discussed adding complementary 
treatments to their current therapy with their consulting 
physician. The most common reasons for CAM use were 
intended by the patients to improve the immune system 
(47%, 136/289), to reduce side effects (43.2%, 125/289), and 
to not miss an opportunity (37.3%, 108/289). Assuming their 
health insurance would not compensate the costs for CAM 
during RT, 52.5% (152/289) of the patients would pay for 
their treatment. A treatment integrated in the individual 
therapy concept, such as regular acupuncture, would be used 
by 62.9% (182/289) of RT patients. In order to gain more 
information about the changes in attitude towards 
complementary medicine, we also handed out the 
questionnaire a second time after RT during the first follow-
up visit (n=10). This is an ongoing part of the evaluation. 
However, it becomes apparent that in retrospect the use of 
CAM increased.  
 
Conclusion: In comparison to other studies, usage of CAM 
parallel to RT is considered to be low. The acceptance 
amongst patients is present, however more information, in 
terms of personal consultations with physicians, brochures or 
online information, could encourage a holistic therapy. 
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Purpose or Objective: On the basis of successful 
intralesional steroid injection for dermatologic scars 
treatment such as keloids and burn scars, we planned to 
evaluate intralesional triamcinolone acetonide injection in 
treatment of RIF as there is no data available for its use for 
this indication 
 
Material and Methods: 30 patients with RIF of different sites 
(19 cases breast, 4 cases neck, 3 back, 2 face and 2 lower 
limbs) at least 6 months after end of radiation were included 
in our study. They were treated by intralesional 
Triamcinolone acetonide injection. Injections were carried 
out by dermojet at 1 cm interval. Injections were repeated 
every 2 weeks for 3months. Assessment was done according 
to RTOG grading before treatment and repeated during and 3 
months after end of treatment. 
 
Results: We documented over all response rates of 80%, 
marked and complete improvement of RIF 43.33%, 30% 
showed one grade improvement, 6.67% had two grades 
improvement, while 20% of patients didn't respond (P-value 
<0.001). Pain score was significantly improved (p value 
<0.001), 44% of the included patients had complete 
improvement of pain, 36% had mild residual pain and 20% of 
patients expressed moderate residual pain. No significant 
adverse events were observed. The results were significantly 
better with younger age group (P-value=0.021), smaller BMI 
(p-value=0.007), patients who received lower radiation doses 
(P value =0.03), smaller number of radiotherapy treatment 
sessions (P-value=0.05), smaller radiation field sizes (P 
value=0.001), and patients with shorter duration of RIF (P 
value <0.001). 
 
Conclusion: Intralesional triamcinolone acetonide injection 
can be considered as an effective in treatment of RIF. It can 
be considered as a promising effective, safe, less costly 
therapeutic option in treatment of RIF. To the best of our 
knowledge, no previous data are available about the use of 
intralesional injection of triamcinolone acetonide for 
treatment of RIF. 
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Purpose or Objective: The only treatment option for 
Ledderhose disease seems radiotherapy as surgery is 
associated with a high chance of recurrence and morbidity. 
